Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease
Enara Herrán,1,2 Catalina Requejo,3 Jose Angel Ruiz-Ortega,4 Asier Aristieta,4 Manoli Igartua,1,2 Harkaitz Bengoetxea,3 Luisa Ugedo,4 Jose Luis Pedraz,1,2 Jose Vicente Lafuente,3 Rosa Maria Hernández1,2 1NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque...
Guardado en:
Autores principales: | Herrán E, Requejo C, Ruiz-Ortega JA, Aristieta A, Igartua M, Bengoetxea H, Ugedo L, Pedraz JL, Lafuente JV, Hernández RM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a465628eec9d4a84ab7a94e9e046e0d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DETERMINATION OF ANTIPARKINSONISM DRUG ENTACAPONE
por: GADALLAH MOHAMED,NASHWAH, et al.
Publicado: (2010) -
Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity
por: Hernández MR, et al.
Publicado: (2012) -
Choroidal neovascularization after intraocular foreign body
por: Fernández-López E, et al.
Publicado: (2014) -
Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application
por: Insausti CL, et al.
Publicado: (2014) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Anna Kelemen, et al.
Publicado: (2010)